To each their own. Personally I will start feeling the AGI as soon as we move from chatting about benchmark results to learn that some lab just announced the discovery of tens of novel treatments for rare diseases.
Maybe I'm too boring but it seems quite pointless to have this same prediction game every time a new model is released.
I think treatment is not good benchmark - it requires lots of waiting and lots of regulatory work. The better benchmark - in my opinion- would be math discovery.
Wouldn’t that be ASI? I.e. surpassing humans by outputting novel treatments at a far greater rate than normal humans?